Menjoge S - Search Results

1

Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.

Hodder R, Kesten S, Menjoge S, Viel K. Hodder R, et al. Among authors: menjoge s. Int J Chron Obstruct Pulmon Dis. 2007;2(2):157-67. Int J Chron Obstruct Pulmon Dis. 2007. PMID: 18044688 Free PMC article.

2

One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium.

Anzueto A, Tashkin D, Menjoge S, Kesten S. Anzueto A, et al. Among authors: menjoge s. Pulm Pharmacol Ther. 2005;18(2):75-81. doi: 10.1016/j.pupt.2004.10.003. Epub 2004 Dec 20. Pulm Pharmacol Ther. 2005. PMID: 15649848

3

Tiotropium in COPD patients not previously receiving maintenance respiratory medications.

Adams SG, Anzueto A, Briggs DD Jr, Menjoge SS, Kesten S. Adams SG, et al. Among authors: menjoge ss. Respir Med. 2006 Sep;100(9):1495-503. doi: 10.1016/j.rmed.2006.03.034. Epub 2006 May 15. Respir Med. 2006. PMID: 16698259 Free article. Clinical Trial.

4

Patient-level pooled analysis of the effect of tiotropium on COPD exacerbations and related hospitalisations.

Halpin D, Menjoge S, Viel K. Halpin D, et al. Among authors: menjoge s. Prim Care Respir J. 2009 Jun;18(2):106-13. doi: 10.4104/pcrj.2009.00017. Prim Care Respir J. 2009. PMID: 19407916 Free PMC article.

5

Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).

Friedman M, Menjoge SS, Anton SF, Kesten S. Friedman M, et al. Among authors: menjoge ss. Pharmacoeconomics. 2004;22(11):741-9. doi: 10.2165/00019053-200422110-00004. Pharmacoeconomics. 2004. PMID: 15250751 Clinical Trial.

6

Tolerance to bronchodilating effects of salmeterol in COPD.

Donohue JF, Menjoge S, Kesten S. Donohue JF, et al. Among authors: menjoge s. Respir Med. 2003 Sep;97(9):1014-20. doi: 10.1016/s0954-6111(03)00131-8. Respir Med. 2003. PMID: 14509555 Free article. Clinical Trial.

7

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators. Tashkin DP, et al. Among authors: menjoge s. N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5. N Engl J Med. 2008. PMID: 18836213 Free article. Clinical Trial.

8

Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD.

Friedman M, Serby CW, Menjoge SS, Wilson JD, Hilleman DE, Witek TJ Jr. Friedman M, et al. Among authors: menjoge ss. Chest. 1999 Mar;115(3):635-41. doi: 10.1378/chest.115.3.635. Chest. 1999. PMID: 10084468 Clinical Trial.

9

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.

Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr. Casaburi R, et al. Among authors: menjoge ss. Eur Respir J. 2002 Feb;19(2):217-24. doi: 10.1183/09031936.02.00269802. Eur Respir J. 2002. PMID: 11866001 Free article. Clinical Trial.

10

A 4-year trial of tiotropium in chronic obstructive pulmonary disease (UPLIFT trial).

Tashkin D, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M. Tashkin D, et al. Among authors: menjoge s. Rev Port Pneumol. 2009 Jan-Feb;15(1):137-40. doi: 10.1016/S0873-2159(15)30121-5. Rev Port Pneumol. 2009. PMID: 25965528 Free article. English, Portuguese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters